Crystal structure of the TetR/CamR family repressor Mycobacterium tuberculosis EthR implicated in ethionamide resistance

Journal of Molecular Biology
Lynn G DoverKlaus Fütterer

Abstract

Ethionamide has been used for more than 30 years as a second-line chemotherapeutic to treat tuberculosis patients who have developed resistance to first-line drugs, such as isoniazid (INH) and rifampicin. Activation of the pro-drug ethionamide is regulated by the Baeyer-Villiger monooxygenase EthA and the TetR/CamR family repressor EthR, whose open reading frames are separated by 75 bp on the Mycobacterium tuberculosis genome. EthR has been shown to repress transcription of the activator gene ethA by binding to this intergenic region, thus contributing to ethionamide resistance. We have determined the crystal structure of EthR, to 1.7A resolution, revealing a dimeric two-domain molecule with an overall architecture typical for TetR/CamR repressor proteins. A 20A long hydrophobic tunnel-like cavity in the "drug-binding" domain of EthR is occupied by two 1,4-dioxane molecules, a component of the crystallisation buffer. Comparing the present structure to those of the homologues Staphylococcus aureus QacR and Escherichia coli TetR leads to the hypothesis that the hydrophobic cavity constitutes a binding site for an as yet unknown ligand that might regulate DNA-binding of EthR.

References

Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
Feb 1, 1970·European Journal of Biochemistry·M A Lanéelle, G Lanéelle
Jul 7, 1993·JAMA : the Journal of the American Medical Association·A Mahmoudi, M D Iseman
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
May 20, 1999·Nature Structural Biology·A PerrakisV S Lamzin
Jan 26, 2000·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·L FattoriniG Orefici
Jun 28, 2000·The Journal of Biological Chemistry·A R BaulardG S Besra
Aug 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·A E DeBarberC E Barry
Jan 3, 2001·Acta Crystallographica. Section D, Biological Crystallography·M D WinnG N Murshudov
Dec 12, 2001·Science·M A SchumacherR G Brennan
Feb 2, 2002·The Journal of Biological Chemistry·Tommaso A VannelliPaul R Ortiz de Montellano
Feb 28, 2002·The EMBO Journal·Maria A SchumacherRichard G Brennan
Aug 2, 2002·Expert Opinion on Investigational Drugs·Laurent S Kremer, Gurdyal S Besra
Aug 10, 2002·Progress in Lipid Research·Cécile AsselineauMarie-Antoinette Lanéelle
Oct 24, 2002·Acta Crystallographica. Section D, Biological Crystallography·Thomas C Terwilliger
Nov 12, 2003·The Journal of Biological Chemistry·Marco W FraaijeDick B Janssen
Feb 6, 2004·Journal of Molecular Biology·Ryo NatsumeSueharu Horinouchi
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson

❮ Previous
Next ❯

Citations

Aug 10, 2011·Journal of Medicinal Chemistry·Lynn G Dover, Geoffrey D Coxon
Jul 20, 2010·Nature Structural & Molecular Biology·Darcie J MillerStephen W White
Jul 16, 2008·Proceedings of the National Academy of Sciences of the United States of America·Wilfried WeberMartin Fussenegger
Mar 28, 2009·The Journal of Biological Chemistry·Alvaro HernándezJosé L Martínez
Nov 2, 2006·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Ming LiEdward W Yu
Dec 22, 2006·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Chih-Chia SuQijing Zhang
Jul 27, 2011·Antimicrobial Agents and Chemotherapy·S TheeH S Schaaf
May 29, 2007·Journal of Bacteriology·Rukman S De SilvaF Jon Kull
Jul 5, 2005·Journal of Bacteriology·Katherine M HoffmannRichard G Brennan
Jun 10, 2005·Microbiology and Molecular Biology Reviews : MMBR·Juan L RamosRaquel Tobes
Sep 13, 2015·Protein Science : a Publication of the Protein Society·Tsung-Han ChouEdward W Yu
Jan 23, 2016·Journal of Structural Biology·Babu A ManjasettyAndrzej Joachimiak
Nov 29, 2011·Tuberculosis·James A SeddonH Simon Schaaf
Jun 29, 2015·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Zofia BakułaTomasz Jagielski
Aug 10, 2007·Journal of Molecular Biology·Ruoyu GuEdward W Yu
Feb 14, 2006·Proteins·Jayaraman SeetharamanSubramanyam Swaminathan
Jan 16, 2014·Protein Science : a Publication of the Protein Society·Nitin KumarEdward W Yu
Mar 29, 2014·Biochemical and Biophysical Research Communications·Jade LeibaVirginie Molle
Dec 3, 2014·Journal of Biotechnology·Kristina IrzikLothar Eggeling
Mar 7, 2009·Journal of Molecular Biology·Jianting ZhengT Ashton Cropp
Oct 24, 2007·Journal of Molecular Biology·Ming LiEdward W Yu
May 18, 2017·Angewandte Chemie·Daniel Shiu-Hin ChanChris Abell
Mar 24, 2016·Angewandte Chemie·Mathieu F ChellatRainer Riedl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.